참고문헌
- National Academy of Sciences Institute of Medicine. To err is human: Building a Safer Health System. Washington, DC: National Academy Press; 1999. Available at http://books.nap.edu/books/0309068371/html/. Accessed August 2009.
- Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL and Lipton RB. Identification of Serious Drug-Drug Interactions: Results of the Partnership to Prevent Drug-Drug Interactions. J Am Pharm Assoc 2004; 44(2): 142-151. https://doi.org/10.1331/154434504773062591
- Lazarou J, Pomeranz BH and Corey PN. Incidence of adverse drug reactions in hospitalized patients: a metaanalysis of prospective studies. JAMA 1998; 279: 1200-1205. https://doi.org/10.1001/jama.279.15.1200
- Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC and Hiatt H. The nature of adverse events in hospitalized patients. N Engl J Med 1991; 324: 377-384. https://doi.org/10.1056/NEJM199102073240605
- Johnson JA and Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995; 155: 1949-1956. https://doi.org/10.1001/archinte.1995.00430180043006
- Ernst FR and Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001; 41: 192-199.
- 김민선, 최윤아, 류윤미, 한현주, 이병구, 박경호, 조남춘. 외래환자 처방전상에 나타난 약물 상호작용 실태 및 병원조제담당 약사의 인지도 조사. J Kor Hosp Pharm 1999; 16(2): 252-258.
- 신현택. 전산화 DUR프로그램을 통한 국민건강보험 약제비심사 효율성 향상 방안에 대한 연구. 건강보험심사평가원 연구보고서 2003년 6월.
- 신현택. 약화사고의 규모파악과 예방대책에 대한 정책연구보고서. 2006. 9. 28.
- 배성미. 각 약물의 Drug Use Evaluation에 의한 적정성 추구. J Kor Soc Health-Syst Pharm 2001; 18(4): 433-439.
- Alan L, Betsy S, Thomas R. F, Theodore M. C. Ambulatory Drug Utilization Review: Opportunities for Improved Prescription Drug Use. AJMC 2001; 7(1): 75-83.
- 의약품사용평가(DUR) 학술정보집. 대한약사회 2004년.
- Soumerai SB and Lipton HL. Computer-Based Drug-Utilization Review-Risk, Benefit, or Boondoggle? N Engl J Med 1995; 332: 1641-1645. https://doi.org/10.1056/NEJM199506153322411
- 김수미. 히스타민-2 수용체 길항제의 약물사용평가를 통한의약분업 전후의 약제서비스 질 개선 평가 연구. 서울대학교 보건대학교 석사학위논문 2003년 8월.
- The U.S. Pharmacopeia Drug Utilization Review Advisory Panel. Drug Utilization Review: Mechanisms to Improve Its Effectiveness and Broaden Its Scope. J Am Pharm Assoc 2000; 40(4): 538-545.
- 건강보험심사평가원 .약제정보 -처방조제안전정보 . Available at http://www.hira.or.kr/common/dummy.jsp?pgmid = HIRAF011305000000. Accessed on April, 2010.
- Forni A, Chu HT, Fanikos J. Technology utilization to prevent medication errors. Curr Drug Saf. 2010 Jan; 5(1): 13-8. https://doi.org/10.2174/157488610789869193
- David H. S, Nancy P, Adrianne F, Xiuhai Y, Daniel K, Steven R. S, Dean F. S, Richard Platt, Soumerai S. B. The Impact of Prescribing Safety Alerts for Elderly Persons in an Electronic Medical Record. Arch Intern Med. 2006; 166: 1098-1104. https://doi.org/10.1001/archinte.166.10.1098
- Jean-Pierre G, Jocelyne M, Louise P, Isabelle C, Rene V, Alain M. Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study. BMC Health Medical Research. 2006; 6: 1-11.